NVIV

InVivo Therapeutics
NVIV

Delisted

NVIV was delisted on the 19th of May, 2024.

Back to rankings
 

About: InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

Employees: 6

Financial journalist opinion

Positive
InvestorPlace
1 year ago
Why Is InVivo Therapeutics (NVIV) Stock Up 61% Today?
InVivo Therapeutics (NASDAQ: NVIV ) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biomaterials and biotechnology company this morning. Instead, it looks like heavy trading of NVIV stock is behind today's movement.
See News Rankings
Charts implemented using Lightweight Charts™